REFERENCES
- Lerner UH. Bone remodeling in post-menopausal osteoporosis. J Dent Res 2006;85:584–595.
- Weitzmann M, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 2006;116:1186–1194.
- Lorentzon M, Lorentzon R, Nordström P. Interleukin-6 gene polymorphism is related to bone mineral density during and after puberty in healthy white males: a cross-sectional and longitudinal study. J Bone Miner Res 2000;15:1944–1949.
- Janiec W. Kompendium Farmakologii. Warszawa: PZWL; 2006.
- Pluskiewicz W, Rogala E. Osteoporoza. Katowice: Śląska Akademia Medyczna; 1995:9–11.
- Jędrzejczak WW, Podolak-Dawidziak M. Cytokiny. Zastosowanie kliniczne. Wrocław: Wyd. Volumed s. c., 1997.
- Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 1996;11:1043–1051.
- Kmieć Z, Sokołowska I. Role of tumor necrosis factor family ligands in the pathogenesis of rheumatoid arthritis–new therapeutical opportunities. Pol Merkur Lekarski. 2007;22:300–304.
- Dirschnabel AJ, Alvim-Pereira F, Alvim-Pereira CC, . Analysis of the association of IL1B(C-511T) polymorphism with dental implant loss and the clusterization phenomenon. Clin Oral Impl Res 2011;22:1235–1241.
- Knudsen S, Harslřf T, Husted LB, . The effect of interleukin-1a polymorphisms on bone mineral density and the risk of vertebral fractures. Calcif Tissue Int 2007;80:21–30.
- Zallone A. Direct and indirect estrogen actions on osteoblasts and osteoclasts. Ann N Y Acad Sci 2006;1068:173–179.
- Tani-Ishii N, Tsunoda A, Teranaka T, Umemoto T. Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha. J Dent Res 1999;78:1617–1623.
- Dinarello CA. Introduction of interleukin-1 and interleukin-1 receptor antagonist. Semin Oncol 1997;24:81–93.
- Krum SA, Miranda-Carboni GA, Hauschka PV, . Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J 2008;27:535–545.
- Navazesh M, Kumar SK. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc 2008;139:35–40.
- Wong DT. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc 2006;137:313–321.
- Mitwally MF, Gotlieb L, Casper RF. Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndrome. Menopause 2002;9:236–241.
- Komulainen MH, Kröger H, Tuppurainen MT, . HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women: a 5 year randomized trial. Maturitas 2008;61:85–94.
- Cohen-Solal M, Graulet A, Gueris J, . Bone resorption at the femoral neck is dependent on local factors in nonosteoporotic late postmenopausal women: an in vitro-in vivo study. J Bone Miner Res 1995;10:307–314.
- Grobelna M, Mroczko B, Czygier M, Szmitkowski M. Cytokiny jako markery osteolizy w diagnostyce pacjentów z przerzutami nowotworowymi do kości. Postepy Hig Med Dosw 2008;62:668–675.
- Di Iorio A, Ferrucci L, Sparvieri E, . Serum IL-1β levels in health and disease: a population-based study. ‘The InCHIANTI study’. Cytokine 2003;22:198–205.
- Mirrielees J, Crofford LJ, Lin Y, . Rheumatoid arthritis and salivary biomarkers of periodontal disease. J Clin Periodontol 2010;37:1068–1074.
- Wilson R, Spiers A, Ewan J, . Effects of high dose oestrogen therapy on circulating inflammatory markers. Maturitas 2009;62:281–286.
- Cantatore FP, Loverro G, Ingrosso AM, . Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause. Clin Rheumatol 1995;14:157–160.
- Vural P, Akgul C, Canbaz M. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women. Pharmacol Res 2006;54:298–302.
- Cyprysiak G, Tadeusiak W. Zastosowanie śliny w diagnostyce medycznej. Nowa Stomatol 2001;2:33–36.
- Król K, Grocholewicz K. Some salivary proteins as a biomarkers of local and general diseases. Literature review. Ann Acad Med Stetin. 2007;53:78–82.